STING1 and melanoma: Indeed, STING-deficient mice were unable to respond to anti-PD-1 and anti-CTLA-4 in B16F10 melanoma model, and cGAMP administration along with ICB inhibited tumor and metastasis formation and delayed tumor growth (80).